BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 785084)

  • 1. [Is a medical treatment of glaucomatous field defects possible? Results of a double blind study (author's transl)].
    Leydhecker W
    Klin Monbl Augenheilkd; 1976 May; 168(05):631-6. PubMed ID: 785084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early defects in the visual field in glaucoma (author's transl)].
    Drance SM; Susanna R; Fairclough M
    Klin Monbl Augenheilkd; 1978 Oct; 173(4):519-23. PubMed ID: 732167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E
    Ophthalmology; 2003 Feb; 110(2):359-62; discussion 362-4. PubMed ID: 12578781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
    Horn FK; Wakili N; Jünemann AM; Korth M
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bencyclan (Fludilat) in the treatment of patients with ischaemic cerebral infarction (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1976 Sep; 71(39):1611-6. PubMed ID: 790129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual field defect after pars plana vitrectomy.
    Yan H; Dhurjon L; Chow DR; Williams D; Chen JC
    Ophthalmology; 1998 Sep; 105(9):1612-6. PubMed ID: 9754165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective detection of visual field defects using home TV set.
    Shirato S; Adachi M; Hara T
    Jpn J Ophthalmol; 1991; 35(3):273-81. PubMed ID: 1770667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tilted disc syndrome may mimic false visual field deterioration.
    Vuori ML; Mäntyjärvi M
    Acta Ophthalmol; 2008 Sep; 86(6):622-5. PubMed ID: 18162059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A frequency-doubling perimetric study in normal-tension glaucoma with hemifield defect.
    Kondo Y; Yamamoto T; Sato Y; Matsubara M; Kitazawa Y
    J Glaucoma; 1998 Aug; 7(4):261-5. PubMed ID: 9713784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment.
    Katz J
    Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects.
    Tanito M; Itai N; Dong J; Ohira A; Chihara E
    Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma.
    Chan KC; Poostchi A; Wong T; Insull EA; Sachdev N; Wells AP
    Ophthalmology; 2008 Apr; 115(4):667-72. PubMed ID: 17716733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for glaucomatous visual field loss with frequency-doubling perimetry.
    Johnson CA; Samuels SJ
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):413-25. PubMed ID: 9040475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inapparent visual field defects in multiple sclerosis patients.
    Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
    Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of visual field progression criteria of 3 major glaucoma trials in early manifest glaucoma trial patients.
    Heijl A; Bengtsson B; Chauhan BC; Lieberman MF; Cunliffe I; Hyman L; Leske MC
    Ophthalmology; 2008 Sep; 115(9):1557-65. PubMed ID: 18378317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
    Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
    Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.